We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+0.38%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.1B
AUM Growth
-$502M
(-4%)
Cap. Flow
-$489M
Cap. Flow
% of AUM
-4.05%
Top 10 Holdings %
Top 10 Hldgs %
13.99%
Holding
580
New
160
Increased
90
Reduced
147
Closed
142
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Check Point Software Technologies
CHKP
|
+$181M |
| 2 |
Philip Morris
PM
|
+$152M |
| 3 |
Broadcom
AVGO
|
+$140M |
| 4 |
Bank of America
BAC
|
+$111M |
| 5 |
Dominion Energy
D
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AutoZone
AZO
|
+$193M |
| 2 |
GE Aerospace
GE
|
+$149M |
| 3 |
Acuity Brands
AYI
|
+$143M |
| 4 |
KeyCorp
KEY
|
+$133M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.78% |
| 2 | Industrials | 13.32% |
| 3 | Healthcare | 10.76% |
| 4 | Energy | 9.69% |
| 5 | Consumer Discretionary | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Calix
CALX
$2.39B
| $2.87M | 0.02% |
+418,246
| New | +$2.7M |
|
|
ARRY
327
DELISTED
Array Biopharma Inc
ARRY
| $2.83M | 0.02% |
+173,438
| New | +$2.78M |
|
|
SCPH
328
DELISTED
scPharmaceuticals
SCPH
| $2.77M | 0.02% |
223,438
+48,438
| +28% | +$651K |
|
329
Microchip Technology
MCHP
$46B
| $2.77M | 0.02% |
+60,646
| New | +$2.79M |
|
330
Silicom
SILC
$242M
| $2.73M | 0.02% |
+79,472
| New | +$4.84M |
|
|
STEL
331
DELISTED
Stellar Bancorp
STEL
| $2.63M | 0.02% |
89,197
+49,197
| +123% | +$1.42M |
|
|
CMTA
332
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $2.57M | 0.02% |
169,670
+89,670
| +112% | +$1.46M |
|
|
AKAO
333
DELISTED
Achaogen Inc
AKAO
| $2.57M | 0.02% |
198,214
-101,786
| -34% | -$1.15M |
|
|
FPRX
334
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.55M | 0.02% |
+148,661
| New | +$2.9M |
|
335
OrthoPediatrics
KIDS
$595M
| $2.51M | 0.02% |
166,526
+17,926
| +12% | +$317K |
|
|
CSLT
336
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $2.31M | 0.02% |
633,516
-1,369
| -0.2% | -$5.08K |
|
337
KALA BIO
KALA
$14.5M
| $2.3M | 0.02% |
58
-18
| -24% | -$684K |
|
338
Bridgewater Bancshares
BWB
$603M
| $2.29M | 0.02% |
+175,000
| New | +$2.26M |
|
339
Lam Research
LRCX
$390B
| $2.26M | 0.02% |
+111,270
| New | +$2.2M |
|
340
Q32 Bio
QTTB
$464M
| $2.24M | 0.02% |
+6,667
| New | +$2.24M |
|
341
Cardlytics
CDLX
$21.5M
| $2.24M | 0.02% |
+15,290
| New | +$2.59M |
|
|
NPTN
342
DELISTED
NEOPHOTONICS CORP
NPTN
| $2.2M | 0.02% |
+320,513
| New | +$2.04M |
|
|
NVTA
343
DELISTED
Invitae Corporation
NVTA
| $2.11M | 0.02% |
+450,000
| New | +$3.21M |
|
344
UnitedHealth
UNH
$370B
| $2.05M | 0.02% |
9,587
-11,233
| -54% | -$2.57M |
|
|
CCT
345
DELISTED
Corporate Capital Trust, Inc.
CCT
| $2.04M | 0.02% |
+120,596
| New | +$1.93M |
|
346
CALL
Simply Good Foods
SMPL
$982M
| $2.03M | 0.02% |
147,612
-252,388
| -63% | -$3.46M |
|
347
General Dynamics
GD
$106B
| $1.99M | 0.02% |
+8,984
| New | +$1.95M |
|
|
GNCA
348
DELISTED
Genocea Biosciences, Inc.
GNCA
| $1.93M | 0.02% |
+229,351
| New | +$1.9M |
|
|
NCNA
349
NuCana
NCNA
$6.12M
| $1.88M | 0.02% |
20
-5
| -20% | -$475K |
|
350
Zymeworks
ZYME
$1.67B
| $1.87M | 0.02% |
155,539
-18,387
| -11% | -$199K |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q1 2018 Portfolio in Review
As of Q1 2018, Alyeska Investment Group held 580 positions worth $12.1B, down 4% from $12.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Alyeska Investment Group withdrew a net $489M in Q1 2018, closing 142 positions and reducing 147 holdings. Its most notable exit was GE Aerospace, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Alyeska Investment Group opened a new position in Philip Morris worth $145M.
- Alyeska Investment Group's largest Q1 2018 buy was Philip Morris: 1,458,712 shares worth $145M.
- Alyeska Investment Group added most to Check Point Software Technologies in Q1 2018, an estimated $181M increase.
- Alyeska Investment Group's biggest Q1 2018 reduction was AutoZone, cutting an estimated $193M.
- Alyeska Investment Group fully exited GE Aerospace in Q1 2018, selling an estimated $149M.
- Alyeska Investment Group's ten largest holdings make up 14% of its $12.1B portfolio in Q1 2018.
- Alyeska Investment Group opened 160 new positions and closed 142 in Q1 2018.
- Alyeska Investment Group's portfolio value fell 4% quarter-over-quarter to $12.1B.
Based on Alyeska Investment Group's 13F filing for Q1 2018, filed 15 May 2018.